Last updated: March 10, 2025
Sponsor: IRCCS SYNLAB SDN
Overall Status: Active - Recruiting
Phase
N/A
Condition
Kidney Stones
Treatment
N/AClinical Study ID
NCT06869603
3/23
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients with idiopathic relapsing nephrolithiasis with evidence instrumental ofbilateral renal stones or emission of more than one stone in the past 5 years
Exclusion
Exclusion Criteria:
Patients who had albumin-corrected plasma calcium levels > 11.0 mg/dl at the time ofthe first determination of serum levels of 25 OH vitamin D;
Patients who had glomerular filtration rate < 60 mL/min/1.73 m2;
Patients who had positive personal history of chronic granulomatous disease;
pregnancy patients;
Positive personal history for morphological abnormalities of the excretory system;
incomplete data collection.
Study Design
Total Participants: 50
Study Start date:
December 07, 2023
Estimated Completion Date:
December 31, 2026
Connect with a study center
Irccs Synlab Sdn
Naples, 80143
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.